| Covered Uses: | All FDA approved indications not otherwise excluded from Part D. |
| Exclusion Criteria: | |
| Required Medical Information: | ALK positive measured by either Abbott's Vysis ALK Break Apart FISH probe test or another reliable CLIA approved testing method (for example RT-PCR, FISH, or IHC) locally advanced or metastatic NSCLC |
| Age Restrictions: | |
| Prescriber Restrictions: | |
| Coverage Duration: | 12months |
| Other Criteria: |